Human Metabolome Technologies, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3794530000
  • TKS: 6090
JPY
609.00
-5 (-0.81%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
314.75
447.98
466.84
192.38
188.63
581.89
410.31
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
314.75
447.98
466.84
192.38
188.63
581.89
410.31
Raw Material Cost
145.96
129.77
161.62
116.07
113.99
173.36
126.38
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.49
0.45
0.41
0.63
0.46
0.72
0.68
Selling and Distribution Expenses
167.56
156.38
167.23
167.45
179.10
159.15
174.27
Other Expenses
-0.05
-0.05
-0.04
-0.06
-0.05
-0.07
-0.07
Total Expenditure (Excl Depreciation)
313.51
286.15
328.86
283.52
293.09
332.51
300.65
Operating Profit (PBDIT) excl Other Income
1.2
161.8
138
-91.1
-104.5
249.4
109.7
Other Income
-3.54
1.02
0.04
1.25
3.45
-0.91
0.48
Operating Profit (PBDIT)
25.84
190.15
166.59
-62.55
-72.36
276.07
136.90
Interest
0.49
0.45
0.41
0.63
0.46
0.72
0.68
Exceptional Items
0.00
0.00
0.00
17.99
3.67
0.00
20.85
Gross Profit (PBDT)
168.80
318.20
305.22
76.31
74.64
408.54
283.94
Depreciation
28.14
27.30
28.56
27.34
28.65
27.60
26.76
Profit Before Tax
-2.80
162.39
137.62
-72.53
-97.80
247.75
130.31
Tax
-37.44
40.53
-3.42
24.65
-49.85
36.60
1.67
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
34.64
121.86
141.03
-97.18
-47.95
211.15
128.64
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
34.64
121.86
141.03
-97.18
-47.95
211.15
128.64
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
34.64
121.86
141.03
-97.18
-47.95
211.15
128.64
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
1,828.93
1,884.26
1,807.87
1,686.33
1,908.60
2,074.17
1,926.40
Earnings per share (EPS)
6.28
21.9
25.06
-17.11
-8.31
36.22
21.74
Diluted Earnings per share
6.28
21.9
25.06
-17.11
-8.31
36.22
21.74
Operating Profit Margin (Excl OI)
0.39%
36.12%
29.56%
-47.38%
-55.38%
42.86%
26.73%
Gross Profit Margin
8.05%
42.34%
35.6%
-23.49%
-36.66%
47.32%
38.28%
PAT Margin
11.01%
27.2%
30.21%
-50.51%
-25.42%
36.29%
31.35%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Jun 2026 is 66.91% vs -18.04% in Jun 2025

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Jun 2026 is 172.08% vs -426.53% in Jun 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Jun 2026 is 138.79% vs -732.97% in Jun 2025

stock-summary

Interest

YoY Growth in quarter ended Jun 2026 is 0.00% vs -16.67% in Jun 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Jun 2026 has improved from Jun 2025

Compare Quarterly Results Of Human Metabolome Technologies, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Net Sales
314.75
0.00
314.75
Other Operating Income
0.00
0.00
0.00
Total Operating income
314.75
0.00
314.75
Raw Material Cost
145.96
0.00
145.96
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.49
6.95
-6.46
-92.95%
Selling and Distribution Expenses
167.56
39.87
127.69
320.27%
Other Expenses
-0.05
60.00
-60.05
-100.08%
Total Expenditure (Excl Depreciation)
313.51
646.85
-333.34
-51.53%
Operating Profit (PBDIT) excl Other Income
1.24
-646.85
648.09
100.19%
Other Income
-3.54
38.72
-42.26
-109.14%
Operating Profit (PBDIT)
25.84
-608.12
633.96
104.25%
Interest
0.49
6.95
-6.46
-92.95%
Exceptional Items
0.00
35.33
-35.33
-100.00%
Gross Profit (PBDT)
168.80
0.00
168.80
Depreciation
28.14
0.00
28.14
Profit Before Tax
-2.80
-579.75
576.95
99.52%
Tax
-37.44
6.29
-43.73
-695.23%
Provisions and contingencies
0
0
0.00
Profit After Tax
34.64
-586.03
620.67
105.91%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
34.64
-586.03
620.67
105.91%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
34.64
-586.03
620.67
105.91%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
1,828.93
2,473.37
-644.44
-26.06%
Earnings per share (EPS)
6.28
-6.21
12.49
201.13%
Diluted Earnings per share
6.28
-6.21
12.49
201.13%
Operating Profit Margin (Excl OI)
0.39%
0.00%
0.00
0.39%
Gross Profit Margin
8.05%
0.00%
0.00
8.05%
PAT Margin
11.01%
0.00%
0.00
11.01%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 31.48 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is -29.73% vs -4.03% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 66.91% vs -18.04% in Jun 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 3.46 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is -71.62% vs -13.55% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 172.08% vs -426.53% in Jun 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 2.94 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is -84.45% vs 13.57% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 138.79% vs -732.97% in Jun 2025

Quarterly - Interest
Interest 0.05 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 0.00% vs 25.00% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 0.00% vs -16.67% in Jun 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 0.39%
in Jun 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 has improved from Jun 2025

Footer loading